4 citations
,
November 2001 in “Journal of Neuropsychiatry” This case report from the University of Alabama, Birmingham describes a rare paradoxical reaction of increased agitation and hyperactivity in a patient with schizoaffective disorder treated with divalproex sodium.
4 citations
,
August 2001 in “Epilepsia” This narrative review discusses issues in the treatment of epilepsy, focusing on antiepileptic drug compliance, side effects, and the challenges of drug selection; it reports no new clinical findings.
4 citations
,
December 1999 This article outlines various aspects of aesthetic facial surgery, including techniques and adjunct procedures, but reports no new clinical findings.
4 citations
,
February 1988 in “Journal of the American Academy of Dermatology” Congenital triangular alopecia is more common than thought and some treatments can be beneficial for appearance concerns.
3 citations
,
February 2024 in “Patient Preference and Adherence” In this study, the authors suggest that patient safety with isotretinoin in Palestine can be improved by adapting pharmacy and medical practice protocols to better educate patients and ensure adherence to safety monitoring and laboratory ordering.
3 citations
,
August 2023 in “Journal of the American Academy of Dermatology” This research emphasizes the importance of understanding patient experiences related to hair loss, highlighting that race, ethnicity, culture, resources, and mental health greatly affect these experiences. Effective counseling involves clear communication, validation, and shared decision-making to provide appropriate treatment, support, or camouflage options.
3 citations
,
June 2023 in “Australasian journal of dermatology” This study reviews the poorly understood occurrence of secondary alopecia, including scarring and non-scarring types, as a rare side effect of cosmetic procedures, emphasizing the need for awareness and early biopsy when patients experience changes in hair density or loss.
3 citations
,
December 2021 in “Acta dermato-venereologica” This meta-analysis found that patients with androgenetic alopecia had a significantly higher prevalence of metabolic syndrome and poorer metabolic profiles compared to controls, especially among females, those with early onset, and individuals of African ethnicity.
3 citations
,
December 2020 in “International Journal of Women's Dermatology” Scalp micro-wounding helps promote hair growth in female pattern hair loss.
3 citations
,
April 2020 in “British Journal of Dermatology” PRP treatment helps 70.1% of hair loss patients after two sessions.
3 citations
,
February 2019 in “Der Urologe” This review discusses the risk of central nervous side effects, such as dementia and depression, from drugs used to treat lower urinary symptoms related to benign prostatic hyperplasia, and highlights inconsistent evidence across different medications.
3 citations
,
January 2017 in “Journal of clinical and diagnostic research” This case series reported incidents of iatrogenic Cushing's Syndrome linked to high doses of intralesional corticosteroid injections and mesotherapy regimens, highlighting the need for cautious prescription practices and further research on mesotherapy safety.
3 citations
,
April 2015 in “Netherlands Heart Journal” This study reported that male baldness was not significantly linked to the severity of coronary artery disease, challenging previous studies suggesting such an association.
3 citations
,
March 2014 in “Annals of Hepatology” This case report describes irreversible alopecia universalis following discontinuation of Peg-IFN/RBV treatment for chronic hepatitis C, highlighting potential autoimmune side effects of interferon-based therapies.
3 citations
,
February 2014 in “Dermatologic Surgery” Low-dose finasteride may cause muscle weakness and eye issues, but stopping the drug can lead to recovery.
3 citations
,
May 2011 in “Facial plastic surgery clinics of North America” This article reviews the causes and treatments of fine rhytids, highlighting the potential effectiveness of laser rejuvenation therapies but presents no new clinical results.
2 citations
,
May 2025 in “BMJ Open” This study identified significant patient frustration with limited access to treatments for alopecia areata in Germany, exacerbated by the absence of health insurance reimbursement for necessary medications.
2 citations
,
October 2024 in “JCEM Case Reports” This study describes a case of a 35-year-old woman who developed symptoms of hyperandrogenism and disrupted steroidogenesis due to chronic use of electronic cigarettes containing compounds similar to etomidate, despite no genetic mutation indicating 11β-hydroxylase deficiency.
2 citations
,
July 2022 in “Sexual Medicine” This study found that 5-α reductase inhibitors and neuropsychiatric medications were most frequently reported for erectile dysfunction in a national pharmacovigilance database from 2010 to 2020.
2 citations
,
December 2021 in “International Journal of Andrology” This review of legal cases found that 5α-reductase inhibitors, alleged to cause sexual, mental, and physical side effects, have led to numerous lawsuits with increasing litigation expected in the future.
2 citations
,
October 2021 in “Journal of Cosmetic Dermatology” In this randomized trial, the researchers observed that both montelukast and finasteride effectively reduced acne severity and lesion count in women with moderate acne, but finasteride showed greater efficacy. Both medications had transient, non-serious side effects, indicating satisfactory tolerability and safety.
2 citations
,
January 2021 in “Cureus” This case report examines the long-term impact of extensive anabolic-androgenic steroid use on metabolic and cardiovascular health, highlighting adverse effects to guide primary care for this patient group.
2 citations
,
February 2020 in “Chinese Medical Journal” This case report highlights the missed diagnosis of systemic lupus erythematosus in a pregnant woman, leading to her death despite treatment efforts after cesarean section and epidural anesthesia complications.
2 citations
,
September 2017 in “Plastic and reconstructive surgery. Global open” This pilot study found that a single session of nanofat treatment may increase hair thickness and density in male patients with androgenic alopecia, with effects lasting up to 12 months in some cases, though results varied.
This study observed that in a real-world clinical setting in Greece, belimumab effectively controlled disease activity in lupus patients and allowed for a reduction in glucocorticoid dosage, with more pronounced benefits seen in patients who were serologically active at the start of treatment.
2 citations
,
January 2016 Hair restoration surgery can lead to issues like scarring, hair loss, and anxiety, but careful management before and after the procedure can minimize these complications.
2 citations
,
September 2013 in “Journal of Cosmetic Dermatology” This review discusses advancements in managing male androgenetic alopecia, emphasizing long-term restoration techniques like follicular unit grafting combined with medical treatments, and reports no new experimental findings.
2 citations
,
August 2013 in “The Lancet. Diabetes & endocrinology” This report discusses the FDA's third denial of approval for Aveed, a long-acting testosterone injection by Endo Pharmaceuticals, citing continued safety concerns including severe side effects.
2 citations
,
August 2012 in “Aesthetic Plastic Surgery” The letter argues that blaming synthetic hair implants for scalp cancer based on one report is biased and possibly coincidental.
2 citations
,
January 2005 in “PubMed” In this study, females with hirsutism showed higher levels of certain androgens and reported more frequent symptoms such as infertility and increased skin greasiness compared to those without hirsutism.